Publication | Open Access
Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer
44
Citations
42
References
2022
Year
Our work presents the first-in-class selective STAT3 inhibitor WB436B as a potential therapeutic candidate for the treatment of pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1